Company intelligence / Profile preview

Gene Codes

Ann Arbor, Michigan, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Gene Codes Corporation is a leading bioinformatics company specializing in DNA sequence analysis software for academic, forensic, and industrial research. Its flagship product, Sequencher, is a gold-standard tool for DNA assembly and analysis used by scientists in over 60 countries. The company gained significant international recognition for developing the Mass Fatality Identification System (M-FISys), which was instrumental in identifying victims of the World Trade Center disaster. Gene Codes continues to provide advanced software solutions for Sanger sequencing, Next-Generation Sequencing (NGS), and forensic genomics data management.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Gene Codes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene Codes.

Explore the full profile